Clinical Trial

Effect and Safety of Benzathine Penicillin Combined With Etanercept on Spondyloarthritis

Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The purpose of the study is to verify the clinical feasibility of Benzathine penicillin (BPG) /Etanercept (ETN) combination regimen in patients with spondyloarthritis (SpA) and at the same time compare Benzathine penicillin /Etanercept combination regimen and Etanercept maintenance therapy in reducing disease activity, improving patients' clinical symptoms and body function scores, enhancing quality of life, improving imaging performance and safety.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-11-24.
Status change: Not Yet Recruiting → Recruiting 2025-06-23
Trial Details
NCT Number NCT06707194
Lead Sponsor Nanfang Hospital, Southern Medical University
Conditions Spondyloarthritis (SpA), Ankylosing Spondylitis (AS)
Enrollment 340 participants
Start Date 2025-06-14
Primary Completion 2027-03-01 (estimated)
Study Completion 2027-07-31 (estimated)
Updated on ClinicalTrials.gov 2025-06-26